Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia

NCT04848974 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Secondary Acute Myeloid Leukemia

Interventions

DRUG: Cladribine
DRUG: Cytarabine
DRUG: Uproleselan

Sponsor

M.D. Anderson Cancer Center